This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Göggel, R. Articles by Uhlig, S. Search for Related Content PubMed PubMed Citation Articles by Göggel, R. Articles by Uhlig, S.

Platelet-Activating Factor–induced Pulmonary Edema Is Partly Mediated by Prostaglandin E₂, E-Prostanoid 3-Receptors, and Potassium Channels

Division of Pulmonary Pharmacology, Research Center Borstel, Borstel; Department of Pediatrics, Philipps-University of Marburg, Marburg, Germany; and Department of Pharmacology, Kyoto University Faculty of Medicine, Kyoto, Japan

Correspondence and requests for reprints should be addressed to Stefan Uhlig, Ph.D., Division of Pulmonary Pharmacology, Research Center Borstel, Parkallee 22, D-23845 Borstel, Germany. E-mail: suhlig{at}fz-borstel.de

Platelet-activating factor (PAF) is an important endogenous mediator of pulmonary edema in many models of acute lung injury. PAF triggers edema formation by simultaneous activation of two independent pathways; one is mediated by a cyclooxygenase metabolite, and the other is blocked by quinine. We examined the hypothesis that the cyclooxygenase-dependent part of PAF-induced edema is mediated by prostaglandin E₂ (PGE₂). In isolated rat lungs, PAF administration stimulated release of PGE₂ into the venous effluate and increased lung weight as a measure of edema formation. Perfusion with a neutralizing PGE₂ antibody attenuated the PAF-induced edema formation. In vivo, E-prostanoid 3-receptor–deficient mice showed less pulmonary Evans blue extravasation in response to PAF injection than did mice deficient in EP1, EP2, or EP4 receptors. Perfusion of rat lungs with PGE₂ caused pulmonary edema, which was largely prevented by inhibition of voltage-gated potassium channels (25 nM ß-dendrotoxin), but not by blocking calcium-dependent potassium currents (100 µM paxilline). In line with its effects on PGE₂-induced edema formation, ß-dendrotoxin attenuated PAF-induced edema partly if given alone, and completely in combination with quinine. Our findings suggest that PAF-triggered edema is partly mediated by the release of PGE₂, activation of EP3 receptors, and activation of voltage-gated potassium channels.

Key Words: adult respiratory distress syndrome • platelet-activating factor • prostaglandin E₂ • pulmonary edema

This article has been cited by other articles:

				M. Hagenaars, J. T. A. Knape, and E. M. J. M. Backus Pulmonary oedema after high infusion rate of sulprostone Br. J. Anaesth., February 1, 2009; 102(2): 281 - 282. [Full Text] [PDF]

				K. P. O'Dea, M. R. Wilson, J. O. Dokpesi, K. Wakabayashi, L. Tatton, N. van Rooijen, and M. Takata Mobilization and Margination of Bone Marrow Gr-1high Monocytes during Subclinical Endotoxemia Predisposes the Lungs toward Acute Injury J. Immunol., January 15, 2009; 182(2): 1155 - 1166. [Abstract] [Full Text] [PDF]

				S. Uhlig and E. Gulbins Sphingolipids in the Lungs Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1100 - 1114. [Abstract] [Full Text] [PDF]

				G. Y. Park and J. W. Christman Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L797 - L805. [Abstract] [Full Text] [PDF]

				I. Beck-Speier, N. Dayal, E. Karg, K. L. Maier, G. Schumann, M. Semmler, and S. M. Koelsch Oxymetazoline Inhibits Proinflammatory Reactions: Effect on Arachidonic Acid-Derived Metabolites J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 843 - 851. [Abstract] [Full Text] [PDF]

				R. Goggel and S. Uhlig The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema Eur. Respir. J., May 1, 2005; 25(5): 849 - 857. [Abstract] [Full Text] [PDF]

				Y. Gao and J. U. Raj Role of veins in regulation of pulmonary circulation Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L213 - L226. [Abstract] [Full Text] [PDF]

				C. Martin, R. Goggel, A.-R. Ressmeyer, and S. Uhlig Pressor responses to platelet-activating factor and thromboxane are mediated by Rho-kinase Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L250 - L257. [Abstract] [Full Text] [PDF]

				J. Deng, X. Hu, P. S. T. Yuen, and R. A. Star {alpha}-Melanocyte-stimulating Hormone Inhibits Lung Injury after Renal Ischemia/Reperfusion Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 749 - 756. [Abstract] [Full Text] [PDF]

				M. J. Tobin Critical Care Medicine in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 294 - 305. [Full Text] [PDF]